With cases of Covid-19 reaching new heights in the world, some states have to adapt rapidly with their rules and regulations. After seeking advice from the some agency and venue hotel, also considering the traffic control and epidemic prevention, the committee must admit this May is not a good time for holding an event. So after serious consideration, the organizing committee decides to postpone this meeting to May 10-12, 2023 at Tokyo, Japan. Sincerely hope you can understand such a demanded action.
Apart from protecting our participants, rescheduling non-essential gathering and travel also aims to contain the spread of coronavirus disease and protect the health system which will otherwise be overwhelmed. Thank you very much for your understanding in the complex situation.
Event Committee
● Learn Global Market Trends for Advanced Drug Delivery Systems
● Organize up to 100+ Oral Presentations on the Latest Tech Trend
● 300+ Attendees to Exchange Ideas and Build New Networks
● Bring together 30+ Exhibitors and Posters on New Technologies
● Opportunities to Visit the local Natural and Cultural Landscapes
 |
Dr. H. Michael Shepard, President & CEO, Enosi Life Sciences, USA |
 |
Dr. Tom Blundell, Professor, University of Cambridge, UK |
 |
Dr. Ulo Langel, Professor, Stockholm University, Sweden |
 |
Dr. Mats Larsson, Professor, Department of Physics, Stockholm University, Sweden |
 |
Dr. Maria Koufali, Managing Director, Research and Innovation, Nottingham University Hospitals NHS Trust, UK |
 |
Dr. Ferenc Hudecz, Professor, Department of Organic Chemistry, Eötvös L. University, Hungary |
 |
Dr. Sergey Suchkov, Professor, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Russia |
 |
Dr. Jian Yang, Senior Director, Digital Heath, Eli Lilly and Company, USA |
 |
Dr. Yehuda Shoenfeld, Professor, Sheba Medical Center, Tel-Aviv University, Israel |
 |
Dr. Arne Staby, Scientific VP, CMC Project Management, Biologics, Novo Nordisk A/S, Denmark |
 |
Dr. Michael Markert, Vice President and Global Head of CardioMetabolic Diseases Research, Boehringer Ingelheim, Germany |
 |
Dr. Chuang Kee Ong, Associate Director, Centre of Genomics Research, AstraZeneca UK Limited, UK |
 |
Dr. Ved Srivastava, Vice President of Peptide Chemistry, Intarcia Therapeutics, USA |
 |
Dr. Sylvie Pucheu, Founder and CSO, CILcare, France |
 |
Dr. Andreas Seidl, Chief Operating Officer, Leukocare AG, Germany |
 |
Dr. Wilfried Dathe, External Consultant and Head of Medical Research, Heck Bio-Pharma GmbH, Germany |
 |
Dr. Tomoko Mineno, Professor, Takasaki University of Health and Welfare, Japan |
 |
Dr. Richard Denk, Senior Consultant, Aseptic Processing & Containment, SKAN AG, Switzerland |
SDDS-2022 provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at SDDS-2022
• Meet with International Leaders and Senior Officers in the Field of Drug Delivery Systems
• Maximize Your Opportunities for Collaboration
• Explore Business Opportunities in Amsterdam and beyond
• Spotlight Your Technologies and Its Commercial Application
• Superior Networking Opportunities with Senior Professionals and Industry Elites
|
Exhibition Date: |
 |
 |
 |
 |
 |
 |
World High Technology Society
|
© 2003-2022 All rights reserved by BIT Group Global Ltd. |